Infectious Disease Diagnostics Market by Product & Service, Disease Type, Technology, End User - Global Forecast to 2022 - ResearchAndMarkets.com

DUBLIN--()--The "Infectious Disease Diagnostics Market by Product & Service, Disease Type, Technology, End User - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The global infectious disease diagnostics market is expected to reach USD 19.35 billion by 2022 from USD 14.73 billion in 2017, at a CAGR of 5.6%.

Growth in this market can primarily be attributed to factors such as increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics. However, inadequate reimbursement and rising healthcare cost limiting usage of novel diagnostic technologies are expected to restrain the growth of this market during the forecast period.

Based on product & service, the infectious disease diagnostics market is segmented into assays, kits, & reagents; instruments; and services & software. The assays, kits, and reagents segment accounted for the largest share of the global infectious disease diagnostics market in 2017.

The large share of this segment can be attributed to the increasing number of infectious disease diagnostic tests carried out; easy accessibility to a wide range of reagents; and the growing need for reliable, specific, and faster detection of infectious diseases in the early stages.

Geographically, Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).

The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMerieux (France), Bio-Rad (US), and Roche (Switzerland).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Infectious Disease Diagnostics Market, By Product & Service

7 Infectious Disease Diagnostics Market, By Technology

8 Infectious Disease Diagnostics Market, By Disease Type

9 Infectious Disease Diagnostics Market, By End User

10 Infectious Disease Diagnostics Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Biomrieux SA
  • Danaher Corporation
  • Diasorin
  • Luminex
  • Meridian Bioscience
  • Quidel
  • Roche Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/vcsfq6/infectious?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing